Actively Recruiting

Age: 3Months - 72Months
All Genders
NCT04017286

Relationship About Pregnancy Health and Offspring Developmental &Behavioral Outcomes

Led by Chen Li · Updated on 2021-02-01

3000

Participants Needed

5

Research Sites

495 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This topic puts forward a hypothesis: genetic and environmental factors such as major depressive disorder during pregnancy, nutritional status of vitamin A, D, E, and folic acid, intestinal microecology, and bisphenol A exposure, may affect the cognitive development level of the offspring through the genetic correlation with attention deficit hyperactivity disorder, developmental delay/intellectual disability, and major depressive disorder, allelic heterogeneity and pleiotropy of ITIH3 mediated by SNP and CACNB2, neurotransmitters like dopamine, and metabolic pathways, thereby increasing the risk of attention deficit hyperactivity disorder and developmental delay/intellectual disability prevalence on offspring. This topic planning from allelic heterogeneity and pleiotropy of attention deficit hyperactivity disorder and major depressive disorder mediated by SNP, neurotransmitters like dopamine, and metabolic pathways, explores deeply the influences on children's development level and the risk of common neurological disorder caused by genetic and environmental factors during pregnancy, looking for reasonable prevention, early diagnosis of biomarkers and therapeutic targets, in order to provide data support for further improvement and revision of national mother and infant healthcare policy .

CONDITIONS

Official Title

Relationship About Pregnancy Health and Offspring Developmental &Behavioral Outcomes

Who Can Participate

Age: 3Months - 72Months
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Pregnant women aged 20 to 49 years
  • No cognitive impairment and able to complete scale tests
  • Hamilton Depression Scale score less than 8 or mild to moderate depression (score 8 to 35)
  • Provided written informed consent to participate in the study
Not Eligible

You will not qualify if you...

  • Received anti-depression therapy during the first 6 months of pregnancy or during pregnancy
  • Severe depression with Hamilton Depression Scale score of 35 or higher
  • Diagnosed with other mental disorders
  • Diagnosed with neurological diseases
  • Have cognitive dysfunction

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 5 locations

1

The People's Hospital of Yubei District of Chongqing City

Chongqing, Chongqing Municipality, China, 401120

Not Yet Recruiting

2

Chongqing First People's Hospital of Liangjiang New Area

Chongqing, Chongqing Municipality, China, 401121

Not Yet Recruiting

3

The Central Hospital of Jiangjin District of Chongqing City

Chongqing, Chongqing Municipality, China, 402260

Not Yet Recruiting

4

Wanzhou Health Center for Women and Children

Chongqing, Chongqing Municipality, China, 404100

Actively Recruiting

5

The Maternal and Child Health Hospital of Hainan Province

Haikou, Hainan, China, 570000

Not Yet Recruiting

Loading map...

Research Team

L

Li Chen, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here